HighTower Advisors »

Actuate Therapeutics shares owned by HighTower Advisors

Quarter-by-quarter ownership of Actuate Therapeutics (ACTU) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Actuate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Actuate Therapeutics held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Actuate Therapeutics by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $56k 37k 1.53